Table 1.
Correlations between long non-coding RNA TFAP2A-AS1 expression and clinicopathologic characteristics in breast cancer.
| Clinicopathologic characteristics | No. of patients | Long non-coding RNA TFAP2A-AS1 | P value | |
|---|---|---|---|---|
| High | Low | |||
| Age (year) | ||||
| >50 | 21 | 10 (47.6%) | 11 (52.4%) | 0.500 |
| ≤50 | 9 | 5 (55.6%) | 4 (44.4%) | |
| Tumor size (cm) | ||||
| <3 | 19 | 12 (63.2%) | 7 (36.8%) | 0.287 |
| ≥3 | 11 | 5 (45.5%) | 6 (54.5%) | |
| Differentiation grade | ||||
| Well/moderately | 17 | 12 (70.6%) | 5 (29.4%) | 0.035* |
| Poorly/undifferentiated | 13 | 4 (30.8%) | 9 (69.2%) | |
| TNM stage | ||||
| 0 & I & II | 24 | 19 (79.2%) | 5 (20.8%) | 0.049* |
| III & IV | 6 | 2 (33.3%) | 4 (66.7%) | |
*
P<0.05,
TNM stage – pathologic tumor, node, metastasis stage.